StockTipsArenaBeta

BUY Alembic Pharmaceuticals Limited — Manas Jaiswal

BUYAlembic Pharmaceuticals Limited

byManas JaiswalHorizon: NA (inferred Swing (≤2wk))8 May 2026via CNBC Awaaz.

Entry₹794.75Inferred
Target₹840
Total upside +5.69% (call closed)
Stop loss₹774-2.61% risk
Exit₹77411 May 2026, 9:15 am
Stop-loss hit-2.61%
Follow Manas Jaiswal for new calls(31% target hit, 263 closed calls)Get alertsWatch APLLTD for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Sept, 4:23 am IST
1 supporting0 opposing
Supports the BUY call (1)

Alembic Pharmaceuticals Ltd has received final approval from the USFDA for its Fingolimod Capsules, 0.5 mg.

BSE · Company Update·25 Apr · 2w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.